Terms: = Germ cell tumor AND PIK3R1, P27986, 5295, ENSG00000145675, p85-ALPHA, GRB1 AND Treatment
18 results:
1. Pathway-based approach reveals differential sensitivity to E2F1 inhibition in glioblastoma.
Alvarado AG; Tessema K; Muthukrishnan SD; Sober M; Kawaguchi R; Laks DR; Bhaduri A; Swarup V; Nathanson DA; Geschwind DH; Goldman SA; Kornblum HI
Cancer Res Commun; 2022 Sep; 2(9):1049-1060. PubMed ID: 36213002
[TBL] [Abstract] [Full Text] [Related]
2. [Diffuse midline gliomas with H3K27 alteration in children: a clinicopathological analysis of forty-one cases].
Li J; Ma YY; Feng J; Zhao D; Ding F; Tian L; Chen R; Zhao R
Zhonghua Bing Li Xue Za Zhi; 2022 Apr; 51(4):319-325. PubMed ID: 35359043
[No Abstract] [Full Text] [Related]
3. Promising potential of boron compounds against Glioblastoma: In Vitro antioxidant, anti-inflammatory and anticancer studies.
Turkez H; Arslan ME; Tatar A; Mardinoglu A
Neurochem Int; 2021 Oct; 149():105137. PubMed ID: 34293392
[TBL] [Abstract] [Full Text] [Related]
4. PET/CT using
Liu D; Cheng G; Ma X; Wang S; Zhao X; Zhang W; Yang W; Wang J
J Neuroimaging; 2021 Jul; 31(4):733-742. PubMed ID: 34021667
[TBL] [Abstract] [Full Text] [Related]
5. Drug repurposing using transcriptome sequencing and virtual drug screening in a patient with glioblastoma.
Saeed MEM; Kadioglu O; Greten HJ; Yildirim A; Mayr K; Wenz F; Giordano FA; Efferth T
Invest New Drugs; 2021 Jun; 39(3):670-685. PubMed ID: 33313992
[TBL] [Abstract] [Full Text] [Related]
6. Genetic Profiling of Advanced Melanoma: Candidate Mutations for Predicting Sensitivity and Resistance to Targeted Therapy.
Olbryt M; Pigłowski W; Rajczykowski M; Pfeifer A; Student S; Fiszer-Kierzkowska A
Target Oncol; 2020 Feb; 15(1):101-113. PubMed ID: 31980996
[TBL] [Abstract] [Full Text] [Related]
7. Comparative proteogenomic characterization of glioblastoma.
Asif S; Fatima R; Krc R; Bennett J; Raza S
CNS Oncol; 2019 Jun; 8(2):CNS37. PubMed ID: 31290679
[No Abstract] [Full Text] [Related]
8. Polycomb complex mediated epigenetic reprogramming alters TGF-β signaling via a novel EZH2/miR-490/TGIF2 axis thereby inducing migration and EMT potential in glioblastomas.
Vinchure OS; Sharma V; Tabasum S; Ghosh S; Singh RP; Sarkar C; Kulshreshtha R
Int J Cancer; 2019 Sep; 145(5):1254-1269. PubMed ID: 31008529
[TBL] [Abstract] [Full Text] [Related]
9. Next-generation whole exome sequencing of glioblastoma with a primitive neuronal component.
Xu G; Zheng H; Li JY
Brain Tumor Pathol; 2019 Jul; 36(3):129-134. PubMed ID: 30715630
[TBL] [Abstract] [Full Text] [Related]
10. Distinct Molecular Profiles and Immunotherapy treatment Outcomes of V600E and V600K
Pires da Silva I; Wang KYX; Wilmott JS; Holst J; Carlino MS; Park JJ; Quek C; Wongchenko M; Yan Y; Mann G; Johnson DB; McQuade JL; Rai R; Kefford RF; Rizos H; Scolyer RA; Yang JYH; Long GV; Menzies AM
Clin Cancer Res; 2019 Feb; 25(4):1272-1279. PubMed ID: 30630828
[TBL] [Abstract] [Full Text] [Related]
11. The Inhibition of microRNA-128 on IGF-1-Activating mTOR Signaling Involves in Temozolomide-Induced Glioma cell Apoptotic Death.
Chen PH; Cheng CH; Shih CM; Ho KH; Lin CW; Lee CC; Liu AJ; Chang CK; Chen KC
PLoS One; 2016; 11(11):e0167096. PubMed ID: 27893811
[TBL] [Abstract] [Full Text] [Related]
12. Combination of lentivirus-mediated silencing of PPM1D and temozolomide chemotherapy eradicates malignant glioma through cell apoptosis and cell cycle arrest.
Wang P; Ye JA; Hou CX; Zhou D; Zhan SQ
Oncol Rep; 2016 Nov; 36(5):2544-2552. PubMed ID: 27633132
[TBL] [Abstract] [Full Text] [Related]
13. Genomic portfolio of Merkel cell carcinoma as determined by comprehensive genomic profiling: implications for targeted therapeutics.
Cohen PR; Tomson BN; Elkin SK; Marchlik E; Carter JL; Kurzrock R
Oncotarget; 2016 Apr; 7(17):23454-67. PubMed ID: 26981779
[TBL] [Abstract] [Full Text] [Related]
14. Phase II study of PX-866 in recurrent glioblastoma.
Pitz MW; Eisenhauer EA; MacNeil MV; Thiessen B; Easaw JC; Macdonald DR; Eisenstat DD; Kakumanu AS; Salim M; Chalchal H; Squire J; Tsao MS; Kamel-Reid S; Banerji S; Tu D; Powers J; Hausman DF; Mason WP
Neuro Oncol; 2015 Sep; 17(9):1270-4. PubMed ID: 25605819
[TBL] [Abstract] [Full Text] [Related]
15. Somatic mutations of pik3r1 promote gliomagenesis.
Quayle SN; Lee JY; Cheung LW; Ding L; Wiedemeyer R; Dewan RW; Huang-Hobbs E; Zhuang L; Wilson RK; Ligon KL; Mills GB; Cantley LC; Chin L
PLoS One; 2012; 7(11):e49466. PubMed ID: 23166678
[TBL] [Abstract] [Full Text] [Related]
16. Novel somatic mutations to PI3K pathway genes in metastatic melanoma.
Shull AY; Latham-Schwark A; Ramasamy P; Leskoske K; Oroian D; Birtwistle MR; Buckhaults PJ
PLoS One; 2012; 7(8):e43369. PubMed ID: 22912864
[TBL] [Abstract] [Full Text] [Related]
17. Comprehensive genomic characterization defines human glioblastoma genes and core pathways.
Cancer Genome Atlas Research Network
Nature; 2008 Oct; 455(7216):1061-8. PubMed ID: 18772890
[TBL] [Abstract] [Full Text] [Related]
18. Neoadjuvant etoposide, ifosfamide, and cisplatin for the treatment of olfactory neuroblastoma.
Kim DW; Jo YH; Kim JH; Wu HG; Rhee CS; Lee CH; Kim TY; Heo DS; Bang YJ; Kim NK
Cancer; 2004 Nov; 101(10):2257-60. PubMed ID: 15484215
[TBL] [Abstract] [Full Text] [Related]
